Recent Finacing
Recent Raise
Nanopath develops a point-of-care molecular diagnostics platform—disposable cartridges and benchtop reader—that detects DNA/RNA without amplification in ~15 minutes for HPV and urinary tract infections, targeting clinical office use.
